Literature DB >> 11485096

Can treatment of P. vivax lead to a unexpected appearance of falciparum malaria?

D P Mason1, S Krudsood, P Wilairatana, P Viriyavejakul, U Silachamroon, W Chokejindachai, P Singhasivanon, S Supavej, F E McKenzie, S Looareesuwan.   

Abstract

Of 994 patients admitted to the Bangkok Hospital for Tropical Diseases for P. vivax malaria, 104 (10.5%) experienced appearance of Plasmodiumfalciparum following drug treatment for P. vivax . In all patients, P. falciparum parasites were not found by microscopic examination upon admission. The mean time for P. falciparum appearance was 12.6 days after the commencement of chloroquine treatment. Patients experiencing appearance of P. falciparum had significantly lower hematocrit, and greater initial P. vivax parasite counts. We use a mathematical model to explore the consequences of chloroquine treatment of such mixed infections. Both clinical results and features of the model suggest that such "hidden infections" may be quite common, and that the appearance of P. falciparum may be stimulated by treatment of P. vivax.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11485096      PMCID: PMC2518972     

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  20 in total

Review 1.  Interactions between malaria parasites infecting the same vertebrate host.

Authors:  T L Richie
Journal:  Parasitology       Date:  1988-06       Impact factor: 3.234

2.  Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border.

Authors:  S R Meek; E B Doberstyn; B A Gaüzère; C Thanapanich; E Nordlander; S Phuphaisan
Journal:  Am J Trop Med Hyg       Date:  1986-03       Impact factor: 2.345

Review 3.  Multispecies Plasmodium infections of humans.

Authors:  F E McKenzie; W H Bossert
Journal:  J Parasitol       Date:  1999-02       Impact factor: 1.276

4.  Heterologous immunity in human malaria.

Authors:  J E Cohen
Journal:  Q Rev Biol       Date:  1973-09       Impact factor: 4.875

5.  Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections.

Authors:  D P Mason; F E McKenzie
Journal:  Am J Trop Med Hyg       Date:  1999-09       Impact factor: 2.345

6.  Chloroquine sensitivity of Plasmodium vivax in Thailand.

Authors:  S Looareesuwan; P Wilairatana; S Krudsood; S Treeprasertsuk; P Singhasivanon; V Bussaratid; W Chokjindachai; P Viriyavejakul; K Chalermrut; S Walsh D; J White
Journal:  Ann Trop Med Parasitol       Date:  1999-04

7.  Hidden Plasmodium falciparum infections.

Authors:  S Krudsood; P Wilairatana; D P Mason; S Treeprasertsuk; P Singhasivanon; S Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  1999-12       Impact factor: 0.267

8.  The blood-stage dynamics of mixed Plasmodium malariae-Plasmodium falciparum infections.

Authors:  D P Mason; F E McKenzie; W H Bossert
Journal:  J Theor Biol       Date:  1999-06-21       Impact factor: 2.691

9.  High rate of mixed and subpatent malarial infections in southwest Nigeria.

Authors:  J May; F P Mockenhaupt; O G Ademowo; A G Falusi; P E Olumese; U Bienzle; C G Meyer
Journal:  Am J Trop Med Hyg       Date:  1999-08       Impact factor: 2.345

10.  High rate of Plasmodium vivax relapse following treatment of falciparum malaria in Thailand.

Authors:  S Looareesuwan; N J White; S Chittamas; D Bunnag; T Harinasuta
Journal:  Lancet       Date:  1987-11-07       Impact factor: 79.321

View more
  11 in total

1.  Competition for red blood cells can enhance Plasmodium vivax parasitemia in mixed-species malaria infections.

Authors:  Philip G McQueen; F Ellis McKenzie
Journal:  Am J Trop Med Hyg       Date:  2006-07       Impact factor: 2.345

2.  Primaquine administration after falciparum malaria treatment in malaria hypoendemic areas with high incidence of falciparum and vivax mixed infection: pros and cons.

Authors:  Polrat Wilairatana; Noppadon Tangpukdee; Shigeyuki Kano; Srivicha Krudsood
Journal:  Korean J Parasitol       Date:  2010-06-17       Impact factor: 1.341

3.  Maximising the public health benefit of antimalarials.

Authors:  Ric N Price; Nicholas M Douglas
Journal:  Lancet Infect Dis       Date:  2010-09-09       Impact factor: 25.071

4.  A comparative hospital-based observational study of mono- and co-infections of malaria, dengue virus and scrub typhus causing acute undifferentiated fever.

Authors:  S Ahmad; M Dhar; G Mittal; N K Bhat; N Shirazi; V Kalra; H C Sati; V Gupta
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-06       Impact factor: 3.267

5.  Fever in patients with mixed-species malaria.

Authors:  F Ellis McKenzie; David L Smith; Wendy P O'Meara; J Russ Forney; Alan J Magill; Barnyen Permpanich; Laura M Erhart; Jeeraphat Sirichaisinthop; Chansuda Wongsrichanalai; Robert A Gasser
Journal:  Clin Infect Dis       Date:  2006-05-10       Impact factor: 9.079

6.  High-dose primaquine regimens against relapse of Plasmodium vivax malaria.

Authors:  Srivicha Krudsood; Noppadon Tangpukdee; Polrat Wilairatana; Nantaporn Phophak; J Kevin Baird; Gary M Brittenham; Sornchai Looareesuwan
Journal:  Am J Trop Med Hyg       Date:  2008-05       Impact factor: 2.345

7.  Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand.

Authors:  Udomsak Silachamroon; Srivicha Krudsood; Sombat Treeprasertsuk; Polrat Wilairatana; Kobsiri Chalearmrult; Hla Yin Mint; Pannamas Maneekan; Nicholas J White; Victor R Gourdeuk; Gary M Brittenham; Sornchai Looareesuwan
Journal:  Am J Trop Med Hyg       Date:  2003-07       Impact factor: 2.345

8.  Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.

Authors:  Nicholas M Douglas; François Nosten; Elizabeth A Ashley; Lucy Phaiphun; Michèle van Vugt; Pratap Singhasivanon; Nicholas J White; Ric N Price
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079

Review 9.  A review of mixed malaria species infections in anopheline mosquitoes.

Authors:  Mallika Imwong; Supatchara Nakeesathit; Nicholas P J Day; Nicholas J White
Journal:  Malar J       Date:  2011-08-31       Impact factor: 2.979

10.  Author reply.

Authors:  Girish Chandra Bhatt; Tanya Sharma
Journal:  J Pediatr Neurosci       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.